Financial Performance & Capital Allocation - Diamondback generated $1,242 million in Free Cash Flow ("FCF") in Q2 2025, which translates to $425 per share[17] - Adjusted FCF for Q2 2025 was $1,334 million, or $457 per share, excluding $40 million of merger and transaction expenses and $52 million of early derivative termination payments[17] - The company expects to generate at least $58 billion of Adjusted FCF in 2025 at current commodity prices[17] - Approximately 52% of Q2 2025 Adjusted FCF was returned to stockholders, totaling $691 million, through base dividends and share repurchases[15, 17] - The share repurchase authorization was increased by $20 billion, bringing the total to $80 billion, with approximately $35 billion remaining[17] Operational Highlights & Asset Overview - Diamondback's market capitalization is $42,306 million, with net debt of $15,098 million, resulting in an enterprise value of $61,342 million[16] - The company has significant scale with approximately 859,000 net acres and run-rate production of approximately 490 Mbo/d (~905 Mboe/d) beginning in Q3[19] - Diamondback possesses best-in-class inventory depth and quality, with approximately 9,600 gross Permian Basin locations economic at $50 / Bbl[20] - The company's unhedged realized cash margin was 73% in Q2 2025[24] Updated Guidance - The company anticipates full year 2025 oil production to be between 485 and 492 Mbo/d (890 – 910 Mboe/d)[69, 71] - The full year 2025 CAPEX budget is projected to be between $34 and $36 billion[69, 71]

Financial Performance (Q3 2024) - Revenue reached $9535 million, a decrease of 16% compared to $11290 million in Q3 2023[42] - Net loss was $4553 million, primarily due to non-cash adjustments[14] - Adjusted EBITDA was $101 million[14] - Cash balance stood at $253 million[14] Segment Performance (Q3 2024) - Self-Mining revenue was $6814 million, a decrease of 18% compared to $8306 million in Q3 2023[19, 44] - Hosting revenue was $1688 million, a decrease of 38% compared to $2702 million in Q3 2023[19, 44] - HPC revenue was $1034 million, a 100% increase compared to Q3 2023[19, 44] Strategic Initiatives - Signed HPC hosting contracts for approximately 500 MW with potential revenue of $87 billion over 12 years[14, 27] - Refinanced debt, adding cash and eliminating covenants with a $460 million convertible note offering[14] - Reallocated 100 MW of infrastructure from bitcoin mining to HPC hosting[10] Bitcoin Mining - Earned 1115 bitcoin[14] - Operated at 204 EH/s self-mining hash rate[14] - Cash cost to self-mine a bitcoin in Q3 2024 was $42351[26]

FDA Approval and Indication - Revuforj获得FDA批准，用于治疗复发或难治性（R/R）急性髓系白血病（AML），该白血病在1岁及以上的成人和儿童患者中具有易感的NPM1突变，且没有令人满意的替代治疗方案[8] - Revuforj还被批准用于治疗具有KMT2A易位的R/R急性白血病，适用于1岁及以上的成人和儿童患者[11] - Revuforj是首个也是唯一获批用于多种急性白血病亚型的menin抑制剂，适用于成人和儿童[8, 12] Clinical Data and Efficacy - AUGMENT-101关键试验数据显示，Revuforj在R/R NPM1m AML患者中，完全缓解（CR）加上伴有部分血液学恢复的CR（CRh）率为23%[22] - AUGMENT-101试验的中位CR/CRh时间为2.8个月，CR/CRh的中位持续时间为4.5个月[22] - AUGMENT-101试验中，47%的患者达到总缓解率[22] - AUGMENT-101试验的CR/CRh患者中，63%达到MRD阴性[22] - 在缓解者亚组分析中观察到23个月的中位总生存期[22] Market Opportunity and Commercial Strategy - Revuforj在美国R/R急性白血病市场拥有超过20亿美元的市场机会[28] - Revuforj在R/R和一线治疗环境中拥有超过50亿美元的美国市场机会[9, 29] - Revuforj有望成为最大的靶向AML疗法，在可寻址的AML人群中占据40-45%的份额[30, 31] - 通过2025年第二季度，Revuforj已实现65%的一级/二级账户渗透率[34] - Revuforj已列入NCCN指南，用于R/R NPM1m AML和KMT2Ar急性白血病[12, 26]

XmAb819 Clinical Trial - Key Findings - The Phase 1 dose-escalation study of XmAb819 in ccRCC showed a manageable safety profile, with most CRS events being Grade 1/2 and occurring during priming [47, 51, 136] - Correct dose preparation resulted in 4% Grade 3 CRS (2/51), while dose preparation errors led to 28% Grade 3 CRS (5/18) [40, 136] - In the target dose range, correct dose preparation resulted in 6% Grade 3 CRS (1/18), while dose preparation errors led to 50% Grade 3 CRS (3/6) [40, 136] - XmAb819 demonstrated an objective response rate (ORR) of 25% (95% CI: 9-49) and a disease control rate (DCR) of 70% (95% CI: 46-88) in the efficacy-evaluable target dose range (N=20) [55, 89, 125] - The median number of prior regimens for patients in the XmAb819 study was 4 (range: 1-8), with 70% having received ≥3 prior regimens [35, 89, 119] XmAb819 Development & Market Opportunity - Xencor is planning to start a pivotal study of XmAb819 as monotherapy in advanced ccRCC in 2027 [79, 104] - The global RCC market is expected to reach approximately $12 billion by 2030 [80] - In the U S, there are approximately 60,000 new cases of ccRCC per year [84] XmAb541 Early Results - Early data from the Phase 1 dose escalation study of XmAb541 showed promising anti-tumor activity in advanced ovarian cancer, endometrial cancer, and germ cell tumors [4, 93, 97] - The total sales in 1H25 for ovarian cancer drugs were $338 million, and for endometrial cancer drugs were $196 million [100]

Financial Performance - EPS reached $1.37 in 3Q25, compared to $1.08 in 3Q24[6] - Core EPS increased to $1.40 in 3Q25, up from $1.08 in 3Q24, a 30% increase[6, 7] - Core ROA was 1.48%, an increase of 10 bps QoQ and 26 bps YoY[6, 8] - NIM was 3.91%, up 2 bps QoQ and 13 bps YoY[6, 8] - Fee Revenue was $86.5 million, representing 31.9%[6] Balance Sheet & Capital Management - Total Client Deposits reached $17.226 billion, a 5% increase YoY[22] - Noninterest Demand Deposits grew 12% YoY, reaching $5.237 billion[22] - CET1 ratio was 14.39%[6] - $206.2 million of capital was returned to shareholders YTD, including $178.3 million from share repurchases, representing 5.8% of outstanding shares[8] - Tangible book value (TBV) was $32.11 per share, including a negative impact of $8.56 per share related to Reported AOCI[35] Asset Quality - ACL ratio was 1.41%[6]

Financial Performance - Net income for Q3 2025 was $73.8 million[4,5] - Diluted earnings per share (EPS) increased to $0.59 in Q3 2025, compared to $0.58 in Q2 2025[4] - Net interest margin (NIM) increased by 8 basis points to 3.19%[4,6] - The efficiency ratio improved to 55.3% in Q3 2025, compared to 57.2% in Q2 2025[4] Balance Sheet - Total assets increased to $24.0987 billion as of September 30, 2025, compared to $23.8371 billion as of June 30, 2025[8] - Total deposits increased by $498.1 million to $20.7296 billion[8,9] - Total loans and leases decreased by $222.5 million[8,9] Asset Quality - The allowance for credit losses (ACL) to total loans and leases ratio was 1.17%[35,36] - A $4.5 million provision was recorded[6] Capital Management - The CET1 capital ratio was 13.2%[6] - The company repurchased 964 thousand shares of common stock at a total cost of $24 million[9]

Company Overview - PECO's portfolio consists of 300+ properties, primarily anchored centers, totaling 34 million square feet with 98% occupancy[5] - The company's total enterprise value is over $72 billion[7] - 84% of PECO's annualized base rent (ABR) comes from 1 or 2 grocery anchors by sales[7] - The portfolio retention rate is 94%[7] Strategy and Performance - 95% of PECO's ABR is derived from grocery-anchored neighborhood centers[13] - 70% of ABR comes from necessity-based goods and services retailers[22] - PECO's Q3 2025 saw record-high renewal rent spreads of 232%[28] - The company anticipates 2025 Nareit FFO per share growth of 68% at the guidance midpoint[31] - PECO's 2024 grocer sales per square foot (PSF) growth was +50% over 2023[43] Portfolio and Financials - PECO targets $350 million to $450 million in gross acquisitions per year[69] - The company estimates total investment in active development projects at $76 million, with an average estimated yield between 9% and 12%[68] - PECO has a significant liquidity position of $977 million[79]

Financial Performance - Net income available to common shareholders was $32 million, or $032 per diluted share in 3Q25[8, 14] - Pre-tax, pre-provision net income increased 22% from the prior quarter and 96% compared to 3Q24[8] - Gross revenue increased 87% from $242 million in 2Q25 to $263 million in 3Q25[38] - Net interest income increased $16 million, or 89%, from $179 million in 2Q25 to $195 million in 3Q25[43] Balance Sheet & Loan Portfolio - Total deposits increased 126% from $253 billion in 2Q25 to $285 billion in 3Q25[30] - Interest-bearing deposits increased 138% from $217 billion in 2Q25 to $247 billion in 3Q25[30] - New loan production in 3Q25 was $1457 million with an average rate of 638%[25] - Total loans held for investment increased $504 million from the prior quarter[25] Asset Quality & Capital - Tangible book value per share increased 12% to $2368[14] - The efficiency ratio improved from 7883% in 2Q25 and 8498% in 3Q24 to 7638% in 3Q25[55]

Financial Performance - Total assets decreased by 46% compared to 3Q24, reaching $62498 million[6] - Loans held for investment increased by 21% compared to 3Q24, reaching $44196 million[6] - Total deposits increased by 21% compared to 3Q24, reaching $54790 million[6] - Net interest margin, tax equivalent, increased by 106 bps compared to 3Q24, reaching 357%[6] - Diluted EPS increased by 100% compared to 3Q24, reaching $082[6] - Adjusted EPS increased by 50% compared to 3Q24, reaching $087[6] Credit Risk - Nonperforming assets ratio decreased by 12 bps compared to 2Q25, reaching 054%[6] - Net charge-off ratio increased by 136 bps compared to 2Q25, reaching 138%[6] - Allowance for credit losses ratio decreased by 33 bps compared to 2Q25, reaching 117%[6] Wealth Management - Wealth Management Assets Under Administration reached $343 billion in 2025[24] - Net new asset growth YTD 3Q25 of $75 million[26]

Financial Performance - Air Group's adjusted earnings per share was $1.05 in Q3 2025[5] - Unit revenue increased by 1.4% in Q3 2025[5] - Q3 2025 unit costs increased by 8.6%[5] - Economic fuel cost per gallon averaged $2.51 for Q3 2025[5] Strategic Initiatives - Alaska Accelerate initiatives are expected to contribute $400 million[9] - Network initiatives are expected to contribute $100 million[9] - Product initiatives are expected to contribute $150 million[9] - Loyalty initiatives are expected to contribute $150 million[11] - Cargo initiatives are expected to contribute $150 million[11] Balance Sheet - Air Group's debt-to-cap stands at 60%[5] - Adjusted net debt to EBITDAR is at 2.6x[5] Hawaiian Holdings Integration - Card acquisitions are up 48%[13] - Cargo revenue increased 27% year-over-year[13]